Back to Search Start Over

Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method.

Authors :
Rubenstein E
Henneton P
Rivière S
Casanova ML
Broner J
Arnaud E
Oziol E
Le Quintrec M
Moranne O
Jorgensen C
Combe B
Bourdin A
Fontaine C
Schiffmann A
Fraison JB
Hallé O
Fraisse T
Veysseyre F
Taieb G
Aerts C
Crampette L
Alovisetti C
Guis L
Mehlal S
Papinaud L
Le Quellec A
Guilpain P
Mahr A
Source :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 May 03; Vol. 63 (6), pp. 1552-1559.
Publication Year :
2024

Abstract

Objectives: This study aimed to estimate the prevalence of ANCA-associated vasculitis (AAV). That is, granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA), in Southern France in 2018, and evaluate differences among Europeans and non-Europeans.<br />Methods: This population-based, cross-sectional study used four sources (hospitals, community-based physicians, laboratories, National Health Insurance) to identify adults ≥15 years diagnosed with GPA, MPA or EGPA, living in Hérault and Gard in 2018. Cases were defined using the ACR/EULAR classification criteria, and if necessary, the European Medicines Agency algorithm. Prevalence estimates were standardised to the world population and capture-recapture analysis was used to assess the comprehensiveness of the estimation. The influence of geographical origin was evaluated.<br />Results: A total of 202 patients were selected, with 86 cases of GPA (42.6%), 85 cases of MPA (42.1%) and 31 cases of EGPA (15.3%). The standardised prevalence estimates per million inhabitants for 2018 were: 103 (95%CI 84-125) for AAV, 48 (95%CI 35-64) for GPA, 39 (95%CI 28-53) for MPA and 16 (95%CI 9-26) for EGPA, 36 (95%CI 25-50) for anti-PR3 positive AAV, 46 (95%CI 34-61) for anti-MPO positive AAV, and 16 (95%CI 9-26) for ANCA-negative AAV. The global estimation of comprehensiveness by capture-recapture analysis was 80.5%. The number of AAV cases was higher for non-European residents (P = 0.001), particularly for MPA (P < 0.0001).<br />Conclusion: We provide a new estimate of AAV prevalence in France and show a higher prevalence of MPA in non-European patients.<br /> (© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)

Details

Language :
English
ISSN :
1462-0332
Volume :
63
Issue :
6
Database :
MEDLINE
Journal :
Rheumatology (Oxford, England)
Publication Type :
Academic Journal
Accession number :
37819770
Full Text :
https://doi.org/10.1093/rheumatology/kead557